Balance Sheet HealthNegative equity and a sharp 2025 debt increase materially weaken financial flexibility. This elevated leverage raises refinancing and covenant risk, constrains ability to fund scaling of production or trials internally, and increases reliance on dilutive financings or costly debt over the medium term.
Weak Cash GenerationPersistent negative operating and free cash flow means the business does not self-fund growth or R&D reliably. Continued cash burn forces dependence on external capital, heightening dilution and execution risk for multi‑year breeding cycles, and limiting ability to weather crop-season variability or regulatory delays.
Volatile Revenue & ProfitabilityMaterial swings in revenue and margins indicate unstable demand, pricing pressure or cost issues, undermining predictability of cash flows. Such volatility complicates long‑range planning for seed trials, production scaling and commercialization, and raises the probability of repeated financial swings in the near term.